Skip to Main Content
Contribute Try STAT+ Today

After a contentious, two-year battle with federal authorities, a patient charity called Patient Services agreed to pay $3 million to settle allegations of violating federal law by enabling drug makers to pay kickbacks to Medicare patients who took their medicines.

The settlement marks the fourth time in as many months that a patient charity has reached a deal with the U.S. Department of Justice, which has been probing the ties between the pharmaceutical industry and these organizations over concerns they are gaming the system. Over the past two years, numerous pharmaceutical companies have similarly reached settlements.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Forgive me for doubting that what the OIG answers our scribe with will closely align with the Patient Services claims.

Comments are closed.